Mangalam Drugs & Organics informs about outcome of board meeting

16 Mar 2024 Evaluate
Mangalam Drugs & Organics has informed that the Board of Directors of the Company at its meeting held on Friday, March 15, 2024 at the registered office of the Company situated at 3rd Floor, Rupam Building, 239, PD 'Mello Road, Near GPO , Mumbai - 400001, Maharashtra, India has considered and approved the scheme of Merger by Absorption of Mangalam Laboratories (First Transferor Company) and JB Pharma (Formerly known as JB Pharma LLP) (Second Transferor Company) with Mangalam Drugs and Organics (Transferee Company) and their respective shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Scheme). The Scheme is subject to the necessary statutory and regulatory approvals including the approvals of Hon'ble National Company Law Tribunal, the shareholders and creditors of each of the companies. The details/ disclosures required under Regulation 30 of the SEBI Listing Regulations, read with Schedule III thereto and the SEBI Circular are provided in the enclosed Annexure.

The above information is a part of company’s filings submitted to BSE.

Mangalam Drugs&Org. Share Price

106.90 2.10 (2.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.